Discover next-generation cell line and manufacturing methods that boost productivity, improve purity, and remove bottlenecks in bispecific antibody development.
Bispecific antibodies hold enormous therapeutic promise, but manufacturing them at high yield and high purity remains one of the toughest challenges in biologics.
In this free webinar, Senior Scientist Yiting Lim reveals practical, next-generation strategies for improving bispecific antibody expression in CHO cell lines, including an antibiotic-free platform that uses only the glutamine synthetase (GS) selection marker.
You’ll also gain insights into how continuous manufacturing can streamline workflows and accelerate production of complex multi-chain molecules. Whether you’re looking to troubleshoot your current bispecific projects or modernize your approach, this session delivers actionable guidance you can put to work immediately.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
